Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around…
CHENNAI, India, March 2, 2026 /PRNewswire/ -- An 8-month-old male weighing 5.5 kg, known case of Chronic Liver Disease (CLD)…
Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls ShortMORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ -- Metabolon, Inc.,…
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…
New findings show natural hazards such as SCS and wildfire are reshaping global loss patterns and intensifying need for both…
SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current…
DUBAI, UAE, Dec. 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced an emergency…
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most…
- Growing counterfeit cigarette manufacture and distribution leads to severe negative consequences for national credibility and regional economy SEOUL, South…